Association or Underlying Cause?

Clinical Scorecard: Association or Underlying Cause? Tadalafil Use and Glaucoma

At a Glance

Category	Detail
Condition	Clinical topic addressed by the source article: Association or Underlying Cause?
Key Mechanisms	Mechanisms or clinical associations described in the source article.
Target Population	Men with LUTS in a multinational cohort; the article also discusses men taking tadalafil for ED.
Care Setting	The article author considers a baseline comprehensive eye examination and regular IOP and optic nerve monitoring reasonable for men over 50, particularly those with a family history of glaucoma or other eye disease.

Key Highlights

In a multinational cohort of nearly 74,000 men with LUTS, tadalafil use was associated with a 22% higher relative risk of glaucoma over five years than nonuse.
Glaucoma developed in 3.93% of tadalafil users and 3.16% of nonusers, an absolute difference of less than 1%.
The association was reported primarily for POAG and ocular hypertension; no significant association was reported for low-tension or angle-closure glaucoma.
The observational study establishes an association, not causation; the article notes that underlying vascular health may be a plausible alternative explanation.
The article states that these findings should not prompt patients to stop tadalafil.

Guideline-Based Recommendations

Diagnosis

The article reports glaucoma diagnoses in an observational cohort but does not provide diagnostic criteria.

Management

The article author says these findings should not prompt patients to stop tadalafil.
The article author considers a baseline comprehensive eye examination and regular IOP and optic nerve monitoring reasonable for men over 50, particularly those with a family history of glaucoma or other eye disease.

Monitoring & Follow-up

The article author considers regular IOP and optic nerve monitoring reasonable for the specified group.
The article author suggests considering overall vascular health alongside medication use.

Risks

Tadalafil use was associated with higher relative glaucoma risk in the cohort, but the observational design cannot establish that tadalafil caused glaucoma.
The article author describes underlying vascular dysfunction as a biologically plausible alternative explanation, while noting that the study does not prove this explanation.

Patient & Prescribing Data

Over five years, glaucoma occurred in 3.93% of tadalafil users versus 3.16% of nonusers. The article author describes tadalafil as effective and generally well tolerated for LUTS and ED and says the findings should not prompt discontinuation.

Clinical Best Practices

The article author advises interpreting the reported association as observational evidence, not proof of a direct medication effect.
The article author suggests considering shared vascular risk factors and possible underlying vascular dysfunction when discussing the association.
The article author considers a baseline comprehensive eye examination and regular IOP and optic nerve monitoring reasonable for men over 50, especially those with a family history of glaucoma or other eye disease.
The article author suggests discussing overall vascular health as well as medication use.